sFlt-1 is an antiangiogenic soluble protein that mediates its antagonistic effect by binding to and inhibiting the pro-angiogenic proteins—PlGF and VEGF, thus inducing endothelial dysfunction [3]. Here, VEGFA is linked to endothelial dysfunction.